The panel discussed two youth prevention programs - the Give Me a Reason voluntary drug testing program for parents and the This Is (Not) about Drugs prevention program implemented in schools. The Give Me a Reason program provides free at-home drug testing kits for parents to help prevent drug use among youth. The This Is (Not) about Drugs program uses a film and lesson plan to educate students about the risks of prescription opioid and heroin use with the goal of preventing first-time drug use.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Drug Treatment Courts: How America’s Most Trusted Alternative to Incarceration is Providing Hope in the Midst of the Rx Drug Abuse and Opiate Epidemic - Vision Session Presented by National Association of Drug Court Professionals
The video for this presentation is available on our Youtube channel:
https://youtube.com/allceuseducation A continuing education course for this presentation can be found at https://www.allceus.com/member/cart/index/index?c=
Part of the Addiction counselor training curriculum
Preventing Unintended Pregnancy Among Adolescents: Using mHealth to Promote a...YTH
Health-E You/Salud iTu is an mHealth contraceptive decision support tool for adolescent girls. Through an interactive, youth-centered approach, the App provides accurate information (that can be updated in real-time), individually tailored feedback/messages, and a user-driven experience. Based on the youth’s preferences, and experiences, the App provides contraceptive recommendation(s) while also presenting the youth with all of the possible options including videos of providers and youth. Youth can then share information from the App with their provider to help them communicate their needs, interests and questions. In turn, the provider is better prepared for the face-to-face encounter. Pilot testing shows it is feasible to implement, acceptable to adolescents and providers; improves health knowledge; and visit quality. It is being evaluated at 14 school-based health centers using a longitudinal, cluster randomized control trial research design.
This workshop will focus on different exemplary practices of substance use prevention and intervention, focused on e-cigarette & marijuana. Experts from TUPE programs and SBHCs will present examples of youth leadership in substance use prevention, screening, brief intervention, and referral to treatment (SBIRT) protocols, and school policies to address substance use from a restorative framework. We will review recent prevalence data from the California Healthy Kids Survey, discuss the risks of youth vaping and marijuana use according to the research literature, examine the current policies and regulations at the federal, state and school level, and share educational resources for parents, students and educators.
Tuesday Vision Session: Substance Abuse and Mental Health Services Administration (SAMHSA): Examining Prescription Drug Misuse and Abuse from Federal and National Perspectives
ISPCAN Jamaica 2018 - The Impact of Domestic Violence on Children's Functioni...Christine Wekerle
The Impact of Domestic Violence on Children's Functioning: Care Planning Approaches to Foster Trauma-Informed Care
Shannon Stewart, Yasmin Garad, Natalia Lapshini
Role of Health Care workers against Drug abuse & Illicit Trafficking among Ch...Smriti Arora
Support group available for illicit drug abuse and trafficking
Battle against drug abuse and Illicit drug trafficking in Children:- Role of Health care professionals
Caregiver support during covid-19 lock down period
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
1. Youth Prevention Programs
Presenters:
• Chad Napier, Prevention Coordinator for West Virginia and Virginia,
Appalachia High Intensity Drug Trafficking Area
• Kristi Justice, MA, Executive Director, Kanawha Communities That Care
• Justin Phillips, MA, President and Founder, Overdose Lifeline, Inc.
• Kourtnaye Sturgeon, Board Member and Education Committee Chair,
Overdose Lifeline, Inc.
Prevention Track
Moderator: Karen H. Perry, Co-Founder and Executive Director,
Narcotics Overdose Prevention and Education (NOPE) Task Force,
and Member, Rx and Heroin Summit National Advisory Board
2. Disclosures
Kristi Justice, MA; Chad Napier; Justin Phillips,
MA; Kourtnaye Sturgeon; and Karen H. Perry
have disclosed no relevant, real, or apparent
personal or professional financial relationships
with proprietary entities that produce
healthcare goods and services.
3. Disclosures
• All planners/managers hereby state that they or their
spouse/life partner do not have any financial
relationships or relationships to products or devices
with any commercial interest related to the content of
this activity of any amount during the past 12 months.
• The following planners/managers have the following to
disclose:
– John J. Dreyzehner, MD, MPH, FACOEM – Ownership
interest: Starfish Health (spouse)
– Robert DuPont – Employment: Bensinger, DuPont &
Associates-Prescription Drug Research Center
4. Learning Objectives
1. Describe the Give Me a Reason voluntary
drug-testing program as a prevention tool for
parents.
2. Explain how to implement the Give Me a
Reason prevention program in a community.
3. Explain how to implement the prevention
program called This Is (Not) about Drugs.
6. What is the problem In WV ?
• 16.5 percent of WV High School students have taken a RX drug
without a doctor’s prescription 1 or more times during their
life.
• 39 percent of WV High School students reported using
marijuana 1 or more times during their lifetime.
• 19 percent high school students have used marijuana in the
past 30 days.
• 17 percent of high school students were offered, sold or given
illegal drugs by someone on school property during the past
12 months
• 2013 Youth Risk Behavior Survey (YRBS)
7. Everyone KNOWS …
• Drug use destroys
your life and life of
your family
• Drug use is illegal
• Drug use can kill
• Drug use leads to
addiction
• Drug use jeopardizes
your future
opportunities
8. But are FACTS enough?
• Many times Peer Pressure
overrides common sense!
• Some kids just need a
Reason to resist the
temptation to use drugs
9. Why use drug testing kit
• Parents have a responsibility to guide and protect their children!
• Youth are 50 percent less likely to use RX drugs when parents
talk to their children about drugs.
• Drug testing shows your children you are taking a firm stand
against drug use
• Voluntary testing is a logical and simple way to hold your
children accountable to family rules concerning drug use
• It helps build trust and lets them know you care by creating an
opportunity for open discussion
10. Why use drug testing kit
• The goal of a Voluntary Drug Testing Program is help
your child make positive life choices concerning
alcohol and other drugs.
• Voluntary drug testing is a Reason for your children to
say “No” to peer pressure
• They can tell their friends: “I can’t use drugs, my
parents drug test me.”
11. Concerns
• No records are kept on who picks up a kit
• Kits are administered within the privacy of your
family unit
• There is no way to track drug test kits or individual
results
• Kits contain a pre-stamped envelope to report test
results, but no personal data is collected
12. Using drug SalivaScan Test
• SalivaScanTM test is non-invasive
• Testing takes less than 20 minutes
To begin:
• Make sure nothing (food, drink,
gum, tobacco, etc.) is placed in
mouth 10 minutes prior to testing
13. Using drug test kit
• Sweep inside of mouth
(cheeks, gums and
tongue) several times
with collection swab
• Hold inside of closed
mouth until color
appears on stem of swab
• If color has not appeared
after 7 minutes continue
to next step.
14. Using drug test kit
• Insert sponge of collection swab into screening device
• Push until you hear it lock into place
• Once locked, device is airtight, tamper evident and
ready to dispose of or sent to lab for confirmation (if
positive result is indicated)
• Rotate device side to side, front to back, to disperse
specimen within chamber
• Place device on flat surface
15. Using drug test kit
• Results should appear after 10 minutes
• DO NOT read if no results appear after 20 minutes
• Any shade of color in test region should be considered
19. Kanawha County “Give Me A Reason”
Where can I get a free home drug test kit in Kanawha County?
• Kanawha – Charleston Health Department
108 Lee Street E., Charleston, WV 25301, (304)344-5243, Attn: Tina Ramirez
• Blessed Sacrament Roman Catholic Church
305 E Street, South Charleston, WV 25303, (304) 744-5523
• Kanawha County Sheriff’s Office
Lt. Bob Lilly, 304-357-0729
• Partnership for African American Churches
Rev. James Patterson, 304-768-7688
• Oakwood Baptist Church
855 Oakwood Road, Charleston, 25314, (304) 344-2134
• Hansford Senior Center
500 Washington Street, St. Albans, WV 25177, (304) 722-4621
• Kanawha County Emergency Ambulance Authority
Mike Jarrett, 304-345-2312 Ext. 123
• Kanawha County Schools Health Services
The Nurse at Each Middle and High Schools in Kanawha County
23. • Promoted
GMAR at
Parent
Meetings
Adapted
materials to
Kanawha
County
Sharing GMAR
Program at Job
Corp.
Promoted
GMAR at
Events
Successes with GMAR
24. Kanawha County Update
• Kanawha County began with 700 kits
• 342 of GMAR kits have been distributed by sites & KCTC
• Approximately 200 kits are in homes
• 1 was returned from Kanawha County testing positive for marijuana.
• Kanawha County has been given 100 additional GMAR kits
• Kanawha County Remaining kits
25. For more information
• Appalachia HIDTA
– Chad Napier, Director of Prevention/Education
– napierc@ahidta.org
• Kanawha Communities That Care
– Kristi Justice, Executive Director
– director@kanawhactc.org
27. Disclosures
• Justin Phillips, MA - President and Founder, Overdose
Lifeline, Inc. has disclosed no relevant, real or
apparent personal or professional relationship with
proprietary entities that produce health care goods
and services.
• Kourtnaye Sturgeon - Board Member and Education
Committee Chair, Overdose Lifeline, Inc. has
disclosed no relevant, real or apparent personal or
professional relationship with proprietary entities
that produce health care goods and services.
29. An Indiana non-profit dedicated to helping
individuals, families and communities
affected by the disease of addiction.
overdose-lifeline.org
30.
31. We’re here to help
• Working with law enforcement, government, and
communities to advance the laws and resources
available
• Education and prevention
• Harm Reduction
– First responder naloxone overdose reversal kits and training
– Naloxone distribution and training for the individual and
family
• Providing education on the chronic disease of addiction
and prevention information and resources
• Support group and events
33. Responding to the opioid and
heroin epidemic
PREVENT
People from
starting
REDUCE
Overdose rates
• Expand the use of and access to
Naloxone - overdose reversal drug
• First responders and individuals
REVERSE
Overdose
• Student education - prevent the
first use
• Family education - risk factors and
prevention for their children
34. Why prevention?
“We know that evidence-based prevention efforts are the
most effective way to reduce drug use and to support the
roughly 90 percent of American youth who do not use
illicit drugs. This Administration will continue to expand
community-based efforts to prevent drug use, pursue
‘smart on crime’ approaches to drug enforcement,
increase access to treatment, work to reduce overdose
deaths, and support the millions of Americans in
recovery.”
-- Michael Botticelli, Director of National Drug Control Policy.
35. Why prevention?
In total, alcohol, tobacco and illicit drug use exacts
more than $700 billion annually in costs related to
crime, lost work productivity and health care. For
every $1 invested into prevention and early
treatment programs, up to $10 can be saved in
costs related to substance use disorders.
-- ASAM (American Society of Addiction Medicine)
37. About the program
• An efficacy-based, turn-key program that can
be rolled out anywhere in the United States
• Targeting students grades 8 – 12
• Designed to prevent the first use
• All program materials, presenter training, and
support can be found on overdose-lifeline.org
38. Education program objectives
After completing the lesson, students will know and
understand
1. Drug use can lead to heroin use, addiction, overdose,
and death
2. The risks of heroin and prescription pain drug use
3. The impact of heroin, drugs and alcohol on the user
and the user’s family and friends
4. Alternatives to using heroin, drugs, and alcohol
5. The many ways to ask for help and available
information and resources
39. Educational program package
The lesson plan and program materials are mapped to
the program objectives and designed to provide the
student with the opportunity to learn through a guided
and practical exercise -- deepening the students
understanding and retention.
Lesson Plan,
Presenter
Training, Support
& Background
Pre-Lesson
Assessment
Post-Lesson
Assessment
Film Discussion
and
Companion
PowerPoint
After the
Lesson
Takeaway and
Website
Survey Data
40. Lesson plan timeframe
Designed for a 45 minute timeframe with ability to
expand and incorporate a guest speaker from the
recovery community
Pre-Lesson
Assessment
Post-Lesson
Assessment
Film Discussion
and
Companion
PowerPoint
After the
Lesson
Takeaway and
Website
2 MIN 15 MIN 20 MIN 3 MIN 1 MIN1 MIN
Lesson
Introduction
41.
42. Most important message
• Prescription Pain Pills = Heroin, both are Opioids
• Heroin and prescription pills are rarely the
starting point - First is marijuana, alcohol and
other drugs
• When you use opioids and heroin, you lose your
ability to choose
• You can become addicted and you can overdose
with just 1 use, with the 2nd, the 3rd , etc.
43. Feedback
South Vermillion High School Principal Don Harman believes the work of Overdose Lifeline
is vital. “I would encourage every high school principal to contact them and have them
speak to your student body. To me, that right there – every high school and I hate to say
this, some middle schools – that message needs to get out there."
"I appreciate Overdose Lifeline, Inc. for coming out to our high school to present this
lesson on heroin prevention. Heroin use has become an epidemic in our state and it's vital
that our young people become aware of what could potentially happen to them if they
experiment with heroin or opioids." -- Jeff Wright, Indiana High School, Health Teacher
“Indiana Students Against Destructive Decisions (SADD) sees the unique value in this
educational program, as Overdose Lifeline works with law enforcement to deliver a
message that must be shared with young people in the Indianapolis area. Programs like this
have great potential to create positive change in our communities.”
-- Jamie Vickery, State Coordinator Indiana SADD
“The best kind of drug case is the case that don’t have because somebody makes the choice
to not use. And if people, young people especially, that may not have had a lot of information
about narcotics - specifically heroin and addiction - if they have more information, then it will
increase the possibility that they’re going to make good decisions, not bad decisions.”
-- Brent Eaton, Hancock County Prosecutor
44. Students “what did you learn”
“Don’t do any kind of drugs because you
will probably end up somewhere where
you never thought you would be.”
“I learned that drugs are never the right path
to go down and that you should always stay
away from them. Always keep good positive
people in your life to make you a better
person so you don't go down the wrong path.”
“I learned that people normally do other
drugs before doing heroin or prescription
pain medicine. It is sort of like a ladder.”
“That practically any drug out there could
really screw up your plans for life. If I want to
do big things, I can't let something stupid like
a little pill effect my grades, my goals, and my
friendships/relationships. “
“Prescription drugs and heroin are the
same type of drug and are equally
dangerous. Both are opioids, and both
have the potential to end your life.”
“I learned that no matter how confidant
you are that you won't get addicted to a
drug after taking one dose, you can easily
come addicted and its not within your
control. Even trying drugs that aren't as
powerful, will lead to more dangerous
drugs that can severely effect your life.”
“I learned that drugs can really mess up
someone's life. More than anyone thinks in
the first place, but listening to someone
describe how hard it was to get through hit
me in ways that are indescribable.”
45. Presenter resource center
Designed to assist teachers, family, law
enforcement, healthcare professionals,
community members and individuals in the
delivery of the Prescription Pain Medicine
(Opioids) and Heroin Education and Prevention
Program Lesson.
Here you will find the Presenter training and
support materials and the program classroom
materials.
46. Presenter training
On-demand 24X7 access, plus virtual office hours
Live web-based training APR – MAY 2016
90 minute web event via Google Hangouts, a free
video conferencing service
To participate you will need the following:
– Access to the web/internet
– Computer with audio
47. What’s next
• Research study with Indiana University – Purdue
University (evidence-based, efficacy) with School
of Public and Environmental Affairs and School of
Education
• Indiana Department of Education support
expanding through February 2017
• Expand partnerships and alliances
• Regional expansion to OHIO, KENTUCKY, ILLINOIS,
MICHIGAN
• Explore interactive, web-based curriculum
49. THANK YOU
Justin Phillips, 317-828-6883
justin@overdose-lifeline.org
Kourtnaye Sturgeon, 317-409-7256
education@overdose-lifeline.org
PLEASE SHARE AWARENESS OF THE
PROGRAM IN YOUR COMMUNITY
50.
51. Youth Prevention Programs
Presenters:
• Chad Napier, Prevention Coordinator for West Virginia and Virginia,
Appalachia High Intensity Drug Trafficking Area
• Kristi Justice, MA, Executive Director, Kanawha Communities That Care
• Justin Phillips, MA, President and Founder, Overdose Lifeline, Inc.
• Kourtnaye Sturgeon, Board Member and Education Committee Chair,
Overdose Lifeline, Inc.
Prevention Track
Moderator: Karen H. Perry, Co-Founder and Executive Director,
Narcotics Overdose Prevention and Education (NOPE) Task Force,
and Member, Rx and Heroin Summit National Advisory Board
Editor's Notes
Like many states Indiana is in crisis. CDC 2014 report: Overall, Indiana is ranked 14th in the nation for overdose deaths as reported by CDC. Indiana trends, give more reason for concern. CDC 2014 data shows IN is one of the 14 US states with “significant” overdose death rate increases over 2013.
CDC: Heroin use more than doubled among young adults ages 18–25 in the past decade. Following CDC recommendations “Address the strongest risk factor for heroin addiction: addiction to prescription opioid painkillers.” ODL created a prevention program to “reduce prescription opioid pain medicine abuse and heroin use” through education - targeted to students grades 8-12 and their families.
Grant. Focus Group. Model from “The Meth Project”, open source lesson. Approach: Peer to Peer, Measureable, Live in classroom. Pilot: Feedback from student, educators, DOE, school safety specialist, SADD, community collected and incorporated into the program design.
Overdose Lifeline, Inc. has developed this educational program to help inform students regarding the risks of prescription pain medicine (opioids) and heroin use and provide alternatives to using drugs and alcohol in dealing with the issues, stresses, and pressures facing today’s youth.
Packaged in three part. 1) Lesson plan, presenter training, support and background. 2) Lesson materials 3) Survey data for insight and evidence, continuous improvement.
Here you can access:
Information about the education and prevention program and presenter training, access the film, classroom and the After the Lesson materials
Sample of the Online Edition of the Student Worksheet